Back to top

Genentech says FDA accepts sBLA for for Lunsumio VELO

Genentech, a member of the Roche (RHHBY) Group, announced that the U.S. FDA has accepted the company’s supplemental Biologics License Application f...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Roche Holding AG (RHHBY)

Rogers Corporation (ROG)

Roper Technologies, Inc. (ROP)